In a meta-analysis that included 8 RCTs [53], the effect of LMs on the efficacy of PD-1/PD-L1 inhibitors combined with chemotherapy as first-line treatment in lung cancer was evaluated. Here, PDCD1 is linked to lung carcinoma.